In order to clarify the mechanism underlying the preventive effect of
estrogen on atherogenesis, we investigated the role of estrogen in the
regulation of endothelin-1 (ET-1) production and c-Sos mRNA expressio
n, which may contribute to atherogenesis. Plasma ET-1 concentration in
ovariectomized rats (OVX) was twice as high as that in sham-operated
female rats (Sham). Estradiol replacement in OVX rats (OVX + E) decrea
sed plasma ET-1 to the level in Sham (Sham, 0.68 +/- 0.14; OVX, 1.32 /- 0.14; OVX + E, 0.85 +/- 0.12 pg/ml). Metabolic clearance rate of ET
-1 was similar in these three groups of rats, suggesting that the diff
erence in plasma ET-1 was due to production rather than degradation. M
easurement of immunoreactive ET-1 in tissue extract and immunohistoche
mical examination showed that expression of ET-1 in the aortic smooth
muscle cells of OVX was increased. The expression of c-fos mRNA in the
aorta was also increased in OVX compared with Sham and OVX + E. Intra
venous infusion of ET-1 to Sham induced c-fos expression in the aorta,
suggesting the contribution of ET-1 to c-fos expression. Tissue cultu
re study revealed that DNA synthesis was increased in the aorta and fe
moral artery of OVX. These results suggest that inhibition of ET-1 and
c-fos expression is involved in the anti-atherogenic action of estrog
en.